Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04733794 · ClinicalTrials.gov registry record · NA
Feasibility Bowel Dysfunction Program After Low Anterior Resection
A NA study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04733794 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 14 participants.
The verdict
NCT04733794, a NA study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will facilitate a better understanding of the overall experience of our rectal cancer survivors after Low Anterior Resection for rectal cancer. Studies have demonstrated that the development of bowel and genitourinary dysfunction after this procedure is very distressing to patients and can have a significant impact on overall quality of life. By providing interventions that can be performed at home, investigator may alleviate these symptoms in hopes of improving the experience of patients undergoing Low Anterior Resection. By acknowledging these potentially debilitating symptoms in a systematic way, the investigator hopes to reinforce the importance of symptom management in the survivorship phase after treatment has been completed and ultimately facilitate an individual's return to routine activities.
Interventions
- PROCEDURE Stoma reversal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-02-19 |
| Est. Completion | 2018-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04733794
The ClinicalTrials.gov registry entry for NCT04733794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stoma reversal is the first listed.
NCT04733794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04733794 about?
NCT04733794 is a clinical study titled "Feasibility Bowel Dysfunction Program After Low Anterior Resection". This study will facilitate a better understanding of the overall experience of our rectal cancer survivors after Low Anterior Resection for rectal cancer. Studies have demonstrated that the development of bowel and genitourinary dysfunction after this procedure is very distressing to patients and ca...
What is the current status of trial NCT04733794?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-02-19. Estimated completion is 2018-12-18.
What interventions are being tested in trial NCT04733794?
The interventions under investigation include: Stoma reversal (PROCEDURE).
Who is sponsoring clinical trial NCT04733794?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.